Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Allergology International : Official Journal of the Japanese Society of Allergology|November 4, 2022
Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eyeKen Fukuda, Tatsuma Kishimoto, Tamaki Sumi, et al.
Biological & Pharmaceutical Bulletin|September 11, 2007
Cryptomeria japonica-induced allergic conjunctivitis in miceAtsuki Fukushima, Daisuke Shii, Tamaki Sumi, et al.
Japanese Journal of Ophthalmology|November 6, 2010
Aggravation of conjunctival early-phase reaction by Staphylococcus enterotoxin B via augmentation of IgE productionDai Miyazaki, Waka Ishida, Takeshi Tominaga, et al.
Current Eye Research|December 5, 2018
Hyperemia Analysis Software for Assessment of Conjunctival Hyperemia SeverityTsuyoshi Yoneda, Tamaki Sumi, Yasuhiro Hoshikawa, et al.
Journal of Medical Case Reports|June 15, 2007
Amniotic membrane transplantation for wound dehiscence after deep lamellar keratoplasty: a case reportTetsuya Kawakita, Tamaki Sumi, Murat Dogru, et al.
Japanese Journal of Ophthalmology|December 2, 2011
Automated hyperemia analysis software: reliability and reproducibility in healthy subjectsTsuyoshi Yoneda, Tamaki Sumi, Ayako Takahashi, et al.
International Archives of Allergy and Immunology|July 3, 2008
Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitisAtsuki Fukushima, Tamaki Sumi, Waka Ishida, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 14, 2018
Requirement of longer term antiviral therapy in patients with cytomegalovirus anterior uveitis with corneal endothelial cell damageYosuke Harada, Ken Fukuda, Asami Nakahira, et al.
The British Journal of Ophthalmology|April 23, 2013
Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cellsHiroshi Tanaka, Ken Fukuda, Waka Ishida, et al.
Pageof 5